46% of critically ill COVID-19 patients developed HAI according to new study

23 April 2021

A recent Italian publication has studied hospital-acquired infections (HAI) in critically ill COVID-19 patients. 774 patients with COVID-19 treated at intensive care unit (ICU) at 8 hospitals in Italy were included.

The publication1 shows that 46 % of the critically ill COVID-19 patients developed HAI, of which 38 % were caused by multi-drug resistant (MDR) bacteria. It also showed that the most common HAIs were VAP and CRBSI;

  • 50 % of the HAIs were ventilator-associated pneumonia (VAP)
  • 10 % of the HAIs were catheter-related blood stream infections (CRBSI)

Patients with HAI and septic shock had almost double mortality. The authors comment their findings:

Critically ill COVID-19 patients are at high risk for HAIs, especially VAPs and BSIs due to MDR organisms. HAIs prolong mechanical ventilation and hospitalization, and HAIs complicated by septic-shock almost doubled mortality.”

Read the full study >

Bactiguard’s central venous catheters and endotracheal tubes have a unique technology that prevents healthcare-aquired infections in the bloodstream and respitory tract by reducing microbial adhesion. When fewer bacteria attach to the surface of the products, the risk of infection decreases.

Read more about BIP Central Venous Catheter and BIP Endotracheal Tube.

*Grasseli et al. Chest 2021, online ahead of print